Key Takeaways
- Reconcile what the patient actually used before treatment, what was administered in China and what is intended after departure. A prescription is only one of those histories.
- Identify medicines by generic name, active ingredient, strength, formulation and route—not colour, shape or brand alone.
- Give every medicine one explicit action: continue, stop, start, hold, restart on a stated condition/date, taper, or use as needed with a maximum.
- Build the travel-day clock from the last dose in China to the first dose after arrival. Time-zone changes must preserve safe intervals rather than blindly following two local clocks.
- Verify destination and transit-country rules, lawful quantity, original packaging, documents, cold-chain or device needs, and who will prescribe the next supply.
Content
Medication reconciliation fails when two correct-looking lists describe different realities. The hospital list may show what was ordered, the bedside record what was given, and the patient’s bag what they intend to take.
Before leaving China, turn those versions into one executable medication passport.
Put five evidence sources on the table
Collect:
- the best possible pre-treatment medication history;
- medicines actually administered during treatment or admission;
- discharge prescriptions and written changes;
- products physically in the patient’s possession;
- the receiving country’s available products and prescribing plan.
Include prescriptions, over-the-counter products, injections, inhalers, eye/ear drops, patches, creams, herbal medicines, vitamins and supplements. WHO notes that medication discrepancies arise across transitions and recommends structured reconciliation, documentation of changes and communication to patients and future providers [1].
Classify every difference:
- intentional and documented;
- intentional but not yet explained or documented;
- unintentional or uncertain.
Do not “tidy” uncertainty out of the list. Give it an owner and deadline.
Give every medicine a cross-border identity
Record these fields:
Identity field · Why it matters
generic/active ingredient · brands change between countries
Chinese and English product name · connects packaging to the translated list
strength and concentration · the same name can have multiple strengths
dosage form and release type · immediate, delayed and extended release are not interchangeable
route · oral, injection, inhaled, patch, eye, etc.
manufacturer and batch/expiry when relevant · helps verify an unfamiliar product or cold-chain item
indication · prevents accidental continuation after the reason has ended
Photograph all sides of the original labelled package, but keep the physical medicine in its original container. Loose white tablets are not a reliable international identity.
When a home-country equivalent is proposed, compare active ingredient, salt/ester where relevant, strength, formulation, route and release profile. “Same category” is not the same medicine.
Assign one decision verb to every row
Use only explicit actions:
- continue unchanged;
- start with a first-dose date/time;
- stop with a last-dose date/time and reason;
- hold until a stated test, procedure or condition;
- restart on a stated date or after named clinical clearance;
- taper using a full step schedule;
- as needed with indication, minimum interval and maximum daily dose.
Record why each change was made and who authorised it. Pay special attention to anticoagulants, antiplatelet drugs, insulin and other glucose-lowering treatment, steroids, antiseizure medicines, immunosuppressants, antimicrobials, opioids and medicines with required laboratory monitoring.
Check duplicate active ingredients across combination products and brands. An analgesic sold under two different names can still contribute to the same daily total.
Reconstruct last dose, first dose and missed-dose rule
For each time-sensitive medicine, write:
- last dose actually administered in China;
- next dose due;
- minimum/target interval;
- plan across departure, flight, connection and arrival;
- food or fasting relationship;
- missed, delayed or vomited-dose instruction;
- monitoring tied to the dose.
CDC advises travellers crossing time zones to ask the prescriber how timing should change; safe scheduling should reflect time since the last dose, not simply a new wall-clock label [2]. Do not improvise with insulin, anticoagulants, seizure medicines, steroids or other high-risk schedules.
Use a single travel timeline in both departure and destination time. Set alarms only after the clinician or pharmacist approves the schedule.
Make “as needed” medicines measurable
PRN instructions should specify:
- symptom or measured trigger;
- dose and route;
- minimum interval;
- maximum in 24 hours;
- interaction with scheduled medicines;
- when failure of the rescue dose requires clinical contact;
- when the symptom itself is an emergency.
“Take for pain” is incomplete when the medicine can impair breathing, cause sedation, interact with alcohol or duplicate another product. If naloxone, glucagon, epinephrine or another rescue product is supplied, the patient and companion need practical training, storage information and an emergency-care instruction.
Audit the physical supply
Count usable doses, not boxes. The supply calculation should cover:
- days remaining in China;
- door-to-door travel;
- expected time to the first home appointment or refill;
- a reasonable delay margin;
- any dose taper or cycle variation.
Exclude expired, damaged, unlabelled or incorrectly stored stock. Check that tablets, devices, needles, spacers, test strips, dressings and sharps containers match the plan.
CDC recommends carrying an adequate supply in original labelled containers in cabin baggage and retaining prescriptions and documentation [3]. Do not place the only supply in checked baggage. Split backup stock only if packaging, law and safe storage remain intact.
Validate temperature and device conditions
For refrigerated or temperature-sensitive treatment, obtain from the pharmacy or manufacturer:
- labelled storage range before and after first use;
- allowed room-temperature excursion and total time;
- whether freezing, light or agitation causes damage;
- validated carrier and temperature-monitoring method;
- action after an excursion;
- destination storage plan.
A cold bag with an ice pack is not automatically a validated cold chain; direct contact can freeze some products. Do not use a hotel minibar or aircraft refrigerator without confirmation.
For injectors, pumps, sensors or other devices, record model, consumables, batteries, settings, alarms, security documents and failure backup. Airline/security approval and medication legality are separate checks.
Clear every border in the itinerary
Rules can differ at the destination and transit points. Check:
- whether the active ingredient is prohibited or controlled;
- maximum personal quantity;
- prescription or physician-letter requirements;
- translation, legalisation or prior permit;
- rules for injections, liquids, needles, batteries and cold packs;
- whether mailing or another person carrying the medicine is permitted.
The International Narcotics Control Board publishes country-submitted information for travellers carrying controlled medicines, but coverage and currency vary; contact the relevant embassy, regulator or customs authority for the actual itinerary [4]. CDC likewise warns that transit-country rules matter and advises original labelled containers and carry-on transport [5].
Do not assume a medicine legal in China or sold over the counter at home can cross every border. Do not mail medicine or ask an unrelated traveller to carry it without confirmed authority.
Prepare a bilingual medication passport
The passport should contain:
- patient name as on passport, date of birth and hospital record number;
- allergies and reaction details;
- each active medicine’s Chinese and English identity;
- dose, route, schedule, indication and decision verb;
- last dose in China and travel schedule;
- monitoring and warning signs;
- prescriber name, institution and contact;
- controlled/injectable/cold-chain/device explanation;
- list of stopped medicines and why.
Attach copies of prescriptions and a clinician letter on letterhead where needed. CDC provides a template for international medication letters listing patient identity, medicine, dose, route and medical necessity [6]. A letter supports explanation but does not override destination law.
Assign monitoring and prescribing ownership
For every medicine requiring follow-up, state:
- test or observation;
- target or action threshold set by the clinical team;
- due date;
- who orders it;
- who receives and interprets it;
- who contacts the patient;
- who can change or renew the prescription.
Examples include blood count, kidney/liver function, electrolytes, glucose, drug levels, coagulation, blood pressure, infection or immune-toxicity review. Do not leave “check labs at home” without an ordering clinician and decision route.
Confirm the first home prescriber has accepted the case and can legally prescribe the required product. If the Chinese brand is unavailable, send the pharmacological specification early enough for a supervised substitution.
Run a teach-back and bag audit
The patient or companion should explain and show:
- which medicines were stopped and removed from the active bag;
- the next three doses and their clock times;
- how PRN and scheduled medicines differ;
- the maximum daily dose of relevant ingredients;
- what is refrigerated or secured;
- what documents go through customs;
- what symptom triggers urgent care;
- who supplies the next prescription.
Then compare the passport with every item in hand. Quarantine rather than discard uncertain medicine until a pharmacist resolves it; destructive disposal rules differ, and a needed dose may be difficult to replace.
The transition is closed when the list, physical supply, travel clock, border documents, monitoring and receiving prescriber all agree.
Medical disclaimer: This guide provides general medication-continuity information. A qualified prescriber or pharmacist must reconcile the individual regimen and approve timing, substitutions, tapering, monitoring and travel storage. Never stop, start or change a prescription solely from this article.
FAQ
Is the discharge prescription the final medication list?
Only after it has been reconciled against pre-treatment use, actual inpatient administrations and the products in hand. Every discrepancy and stopped medicine needs an explicit explanation.
Should medicines be repacked into a pill organiser for the flight?
Not before border and security checks unless authorities explicitly permit it. Original labelled packaging makes identity and prescription ownership easier to verify; organise doses after arrival if clinically safe.
How should dose times change across time zones?
Use a clinician-approved plan based on the interval from the last dose and the medicine’s risk, not an automatic switch to local clock time. High-risk schedules require individual instructions.
Can I bring controlled or injectable medicine through a connection?
Possibly, but every destination and transit jurisdiction may have different rules on quantity, permits and documentation. Verify the exact itinerary with official authorities and carry original packaging and required letters.
What if the same brand is unavailable at home?
Ask the receiving prescriber or pharmacist to compare active ingredient, strength, form, route and release profile. Do not substitute by brand resemblance or broad drug class; arrange the change before supply runs out.
Sources
- World Health Organization — Medication Safety in Transitions of Care
- U.S. Centers for Disease Control and Prevention — Traveling Abroad with Medicine
- U.S. Centers for Disease Control and Prevention — What to Do When Sick Abroad, Yellow Book
- International Narcotics Control Board — Travelling Internationally with Medicines Containing Controlled Substances
- U.S. Centers for Disease Control and Prevention — Traveling with Prohibited or Restricted Medications
- U.S. Centers for Disease Control and Prevention — International Medication Letter Template